These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11779599)

  • 1. Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States.
    Silverberg K; Daya S; Auray JP; Duru G; Ledger W; Wikland M; Bouzayen R; O'Brien M; Falk B; Beresniak A
    Fertil Steril; 2002 Jan; 77(1):107-13. PubMed ID: 11779599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models of cost-effectiveness of recombinant FSH versus urinary FSH.
    Al-Inany H; Afnan M
    Hum Reprod; 2002 Jun; 17(6):1671-3; author reply 1673-4. PubMed ID: 12042297
    [No Abstract]   [Full Text] [Related]  

  • 4. Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective.
    Balasch J; Barri PN
    J Assist Reprod Genet; 2001 Feb; 18(2):45-55. PubMed ID: 11285980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
    Frydman R; Howles CM; Truong F
    Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.
    Gerli S; Casini ML; Unfer V; Costabile L; Bini V; Di Renzo GC
    Fertil Steril; 2004 Sep; 82(3):573-8. PubMed ID: 15374698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].
    de Mouzon J; Allavena E; Schmitt C; Frappé M
    Gynecol Obstet Fertil; 2004 Jun; 32(6):508-18. PubMed ID: 15217566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of urinary FSH price: a cost-effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA.
    Silverberg K; Schertz J; Falk B; Beresniak A
    Reprod Biomed Online; 2002; 5(3):265-9. PubMed ID: 12470524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial.
    European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone
    Fertil Steril; 2002 Sep; 78(3):520-8. PubMed ID: 12215327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.
    Bergh C; Howles CM; Borg K; Hamberger L; Josefsson B; Nilsson L; Wikland M
    Hum Reprod; 1997 Oct; 12(10):2133-9. PubMed ID: 9402268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant or urinary follicle-stimulating hormone? A cost-effectiveness analysis derived by particularizing the number needed to treat from a published meta-analysis.
    Ola B; Papaioannou S; Afnan MA; Hammadieh N; Gimba S
    Fertil Steril; 2001 Jun; 75(6):1106-10. PubMed ID: 11384634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results from in vitro fertilization and intracytoplasmic sperm injection with purified gonadotrophins (Metrodin HP).
    Wikland M; Nilsson L; Bergh C; Hamberger L
    Horm Res; 1995; 43(5):238-40. PubMed ID: 7782057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of The Feronia and Apis study group.
    Schats R; Sutter PD; Bassil S; Kremer JA; Tournaye H; Donnez J
    Hum Reprod; 2000 Aug; 15(8):1691-7. PubMed ID: 10920087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data.
    Hatoum HT; Keye WR; Marrs RP; Walton SM; Marshall DC
    Fertil Steril; 2005 Mar; 83(3):804-7. PubMed ID: 15749525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome.
    Aboulghar M; Saber W; Amin Y; Aboulghar M; Mansour R; Serour G
    Fertil Steril; 2010 Nov; 94(6):2332-4. PubMed ID: 20188364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.
    van Tilborg TC; Eijkemans MJ; Laven JS; Koks CA; de Bruin JP; Scheffer GJ; van Golde RJ; Fleischer K; Hoek A; Nap AW; Kuchenbecker WK; Manger PA; Brinkhuis EA; van Heusden AM; Sluijmer AV; Verhoeff A; van Hooff MH; Friederich J; Smeenk JM; Kwee J; Verhoeve HR; Lambalk CB; Helmerhorst FM; van der Veen F; Mol BW; Torrance HL; Broekmans FJ
    BMC Womens Health; 2012 Sep; 12():29. PubMed ID: 22989359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.